Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 324 (RNA5SP324) is a non-functional genomic sequence similar to the 5S ribosomal RNA gene. Pseudogenes arise by duplication or retrotransposition and typically accumulate mutations that disrupt their coding or functional capacity[2][4]. “rRNA pseudogenes” are sequences that closely resemble ribosomal RNA genes but no longer produce functional rRNA. Some pseudogenes can be transcribed and, in rare cases, have regulatory roles through the production of non-coding RNAs that interact with microRNAs, RNA-binding proteins, or parental gene transcripts, but there is no evidence that RNA5SP324 encodes a functional RNA or protein or is a validated molecular drug target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 324 (RNA5SP324).